864274-04-4 Usage
Uses
Used in Pharmaceutical Industry:
2-Methylbenzo[d]oxazole-6-carbaldehyde is used as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure and reactivity allow for the development of new drugs with potential therapeutic applications.
Used in Dye Industry:
2-Methylbenzo[d]oxazole-6-carbaldehyde is also utilized as a building block in the preparation of dyes. Its chemical properties contribute to the creation of dyes with specific characteristics, such as color intensity and stability.
Used in Organic Compounds Synthesis:
2-Methylbenzo[d]oxazole-6-carbaldehyde is employed as a versatile component in the synthesis of a wide range of organic compounds, showcasing its importance in organic chemistry.
Used in Medicinal Chemistry Research:
Due to its potential biological and pharmacological activities, 2-Methylbenzo[d]oxazole-6-carbaldehyde is used in research for exploring its applications in the development of new drugs and materials, further expanding its relevance in the field of medicinal chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 864274-04-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,4,2,7 and 4 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 864274-04:
(8*8)+(7*6)+(6*4)+(5*2)+(4*7)+(3*4)+(2*0)+(1*4)=184
184 % 10 = 4
So 864274-04-4 is a valid CAS Registry Number.
864274-04-4Relevant articles and documents
Heterocyclic compound as well as preparation method and application thereof
-
Paragraph 0241-0244, (2021/08/19)
The invention discloses a heterocyclic compound and a preparation method and application thereof. The invention provides a heterocyclic compound as shown in a formula I or pharmaceutically acceptable salt thereof. The compound has the function of inhibiting the activity of PU.1, and can inhibit the transcriptional activity based on liver cell PU.1 dependence and inhibit fibrosis development.
THIAZOLONES FOR USE AS PI3 KINASE INHIBITORS
-
, (2008/06/13)
Invented is a method of inhibiting the activity/function of PI3 kinases using substituted thiazolones. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, ne
NOVEL CHEMICAL COMPOUNDS
-
Page/Page column 33; 61-62, (2010/02/13)
This invention relates to newly identified compounds for inhibiting hYAK3 proteins and methods for treating diseases associated with the imbalance or inappropriate activity of hYAK3 proteins.